Chemotherapy-induced peripheral neuropathy in cancer patients – A four arm randomized trial on the effectiveness of electro-acupuncture

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004448

Enrollment

Registered

2012-10-12

Start date

2000-11-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G63.1

Interventions

Group 1: During a treatment phase of 3 weeks 2-3 sessions of Electro acupuncture a week are scheduled to treat the affected extremities with 4 acupuncture points (6-9 sessions in 3 weeks). Each sessio

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: cancer patients, who are in remission after chemotherapy with taxanes, platinum derivatives or vinca -alkaloids and who present with symptoms of CIPN

Exclusion criteria

Exclusion criteria: progressive cancer

Design outcomes

Primary

Measure	Time frame
change of subjective CIPN complaints, measured on a numerical rating scale (NRS 0-10) at day 0 (begin of treatment), at day 21 (end of treatment), and at day 84 (follow up 12 weeks after begin of treatment).	—

Secondary

Measure	Time frame
Neurophysiological measures (Distal motor latency and Nerve conduction velocity) and Quality of life (EORTC QLQ C30) at day 0 (begin of treatment) and at day 21 (end of treatment).	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 22, 2026